Stryker Hip Recall Information
Do you have the Stryker Rejuvenate or ABG II Hip Replacement System?
Are you uncertain as to what hip replacement system you have?
Have you had any problems with your hip replacement?
You’re not alone. Call your orthopedic surgeon today…then call us for free confidential advice.
The Stryker Rejuvenate and ABG II are modular-neck stem hip replacement systems consisting of interchangeable cobalt and chromium (CoCr) necks and titanium-coated stems. Unlike other defective hip replacement systems, the Rejuvenate and ABG II are not classified as metal-on-metal devices because they do not contain metal ball and socket components. However, because of the cobalt and chromium neck and titanium stem articulation, patients face many of the same risks associated with the defective metal-on-metal hip implant devices. Patients who received the Rejuvenate or ABG II systems report many of the same complications as patients with other failed hip implant devices including, increased metal ion levels in the blood, metal sensitivity, bone deterioration, swelling, pain, pseudotumors and nerve and tissue damages. Patients experiencing any of these symptoms are urged to contact their orthopedic surgeon as soon as possible.
Approved by the U.S. Food and Drug Administration (FDA) in June 2008 and November 2009, the Rejuvenate and ABG II systems were marketed to younger and more active patients. The devices were touted as providing enhanced stability and flexibility by allowing surgeons to closely match the biomechanics of each patient and by reducing the risk of dislocations and costly revision surgeries. According to Stryker, approximately 30,000 Rejuvenate and ABG II systems have implanted in patients since 2007.
On July 6, 2012 Stryker voluntarily recalled the Rejuvenate and ABG II modular-neck stem hip replacement systems due to increased reports of fretting and corrosion at the modular-neck junction. From January to July of 2012, there were 45 adverse reports filed with the FDA. Patients with failed Stryker Rejuvenate or ABG II systems may face complicated revision surgeries. Because of the design of the devices, surgeons must remove the femoral stem, a risky procedure which can be complicated by bone damage, pseudotumors or damaged tissue.
You have legal rights. Call your orthopedic surgeon today and then call us to learn about your legal rights and remedies.
Stryker Rejuventate and Stryker ABG II are registered trademark of Stryker Orthopaedics, Inc. and are used for informational and product identification purposes only.
- Personal Injury Trial Law and Civil Trial Law –
Texas Board of Legal Specialization
- Civil Practice Pretrial Advocate and Trial Advocate –
National Board of Trial Advocacy